Hematologic Diseases
Authors:
- 1 January 2023
- book chapter
- Published by Springer Nature
- p. 251-270
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryThe Lancet Oncology, 2015
- Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJournal of the National Cancer Institute Monographs, 2014
- Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectJNCI Monographs, 2014
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaBlood, 2013
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211Journal of Clinical Oncology, 2009
- The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPBlood, 2006
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000